+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
FEMALE
ID07077876

Study of Conservative Surgery and Hormonal Treatment Outcomes in Women with Endometrial Adenocarcinoma or Atypical Endometrial Hyperplasia

Led by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Updated on 2025-07-22

100

Participants Needed

1

Research Sites

29 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the obstetric and oncological outcomes in women diagnosed with endometrial adenocarcinoma EAC or atypical endometrial hyperplasia AEH who received conservative treatment. This observational, single-center study takes place at the CLASS Hysteroscopy Center in Rome and focuses on patients treated either to preserve fertility or due to medical reasons preventing standard radical surgery. The treatment involves hysteroscopic removal of lesions using a 15 Fr mini-resectoscope, sometimes combined with visual dilation and curettage techniques. After surgery, a 52 mg levonorgestrel-releasing intrauterine device LNG-IUD is placed. In certain cases, especially for patients with higher-grade cancer or poor prognostic markers, oral progestin therapy with Megestrol Acetate is added. Follow-up includes hysteroscopic biopsies at 3, 6, and 12 months. Participants will be monitored for pregnancy rates, miscarriage rates, and live birth rates within 12 months following a confirmed complete response. Researchers will also assess the disease-free interval for up to 12 months after treatment. The total follow-up lasts one year, with periodic biopsies to evaluate treatment response and ongoing health.

CONDITIONS

Brief Title

Surgical and Obstetric Outcomes in Endometrial Adenocarcinoma and Atypical Endometrial Hyperplasia With Conservative Treatment

Research Team

U

URSULA CATENA

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here